Bruce McCarty
Keine laufenden Positionen mehr
Profil
Bruce McCarty worked as an Executive Director of Manufacturing Operations at Cytochroma, Inc., a Principal at Allergan, Inc., and a General Manager at Draxis Pharmaceutica.
He received an undergraduate degree from McGill University and an MBA from Concordia University-Wisconsin.
Ehemalige bekannte Positionen von Bruce McCarty
| Unternehmen | Position | Ende |
|---|---|---|
Draxis Pharmaceutica
 Draxis Pharmaceutica Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Draxis Pharmaceutica is a Canadian company that manufactures pharmaceutical products. The company is based in Montréal, Canada. Draxis Pharmaceutica was acquired by Elan Corp. Plc from Deprenyl Research Ltd. on January 23, 2002 for $1 million. | Corporate Officer/Principal | - |
| ALLERGAN, INC. | Corporate Officer/Principal | - |
Cytochroma, Inc.
 Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Corporate Officer/Principal | - |
Ausbildung von Bruce McCarty
| McGill University | Undergraduate Degree |
| Concordia University-Wisconsin | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Cytochroma, Inc.
Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Health Technology |
Draxis Pharmaceutica
Draxis Pharmaceutica Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Draxis Pharmaceutica is a Canadian company that manufactures pharmaceutical products. The company is based in Montréal, Canada. Draxis Pharmaceutica was acquired by Elan Corp. Plc from Deprenyl Research Ltd. on January 23, 2002 for $1 million. | Health Technology |
